MedPath

A study to investigate the effects of a 4-week intake of the test food on the intestinal environment and the disposition of the test food after a single intake of the test food.

Not Applicable
Conditions
Healthy male adults
Registration Number
JPRN-UMIN000051814
Lead Sponsor
Metagen, Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
16
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Subjects who have a plan or who have taken the food containing quercetin within a month before the trial start or during the trial. (2)Subjects who have a plan or who have taken medication within a month before the pre-test start or during the trial, which would affect the trial result. (3)Subjects who had undergone appendectomy. (4)Subjects who have received the surgery which would affect the trial result within half a year before obtaining a consent. (5)Subjects who are expected to undergo major changes in their living environment such as home and work during this trial. (6)Subjects with irregular dietary habits. (7)Subjects who take excessive alcohol. (8)Subjects whose roomer is planning to join this trial. (9)Subjects who are now under other clinical tests with some kind of medicine/food, or participated in those within 4 weeks before this trial, or will join those after giving informed consent to participate in this trial. (10)Subjects who have previous/current medical history of severe cardiac, hepatic, renal or digestive diseases. (11)Subjects who are allergic to medicines and test foods (related to lactic acid bacteria). (12)Subjects who donated their blood components, and/or whole blood 200 mL within a month before the trial start. (13)Subjects who donated their blood components, and/or whole blood 400 mL within 3 months before the trial start. (14)Subjects whose collected blood volume within the last 12 months before the trial start would reach to 1,200 mL after adding the blood collection in this study. (15) Others who have been determined ineligible by the principal/sub investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath